06:07 EDT Alaunos Therapeutics (TCRT) files $50M mixed securities shelf
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCRT:
- Alaunos Therapeutics Regains Nasdaq Compliance
- Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
- Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
- Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
- Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors